Literature DB >> 16194867

Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.

Kiat T Tan1, Muzahir H Tayebjee, Robert J Macfadyen, Gregory Y H Lip, Andrew D Blann.   

Abstract

Platelet microparticles (PMPs), procoagulant membrane vesicles derived from activated platelets, are elevated in acute myocardial infarction and unstable angina but their relationship to inflammation and indices of coronary artery disease are unclear. We therefore hypothesised that PMPs are related to scores of coronary atheroma and/or coronary stenosis. Our study was completed by comparing PMP data with other platelet markers and with hs-CRP, marking inflammation. We recruited 54 patients attending for coronary angiography, comparing them to 35 age- and sex-matched controls. Peripheral blood was analysed for PMPs, percent platelets positive for CD62P and CD63 (all flow cytometry), soluble P selectin and hsCRP (both immunoassay). Patients exhibited higher PMPs, increased platelet %CD62P, %CD63 and soluble P selectin (all P < 0.01) and hs-CRP (P = 0.0167) than healthy controls. However, analysing only patients with an unequivocal classification, there were no significant (P </= 0.01) correlations with coronary atheroma or coronary stenosis. These findings provide no support for the hypothesis that PMPs are related to the degree of coronary artery disease and therefore may simply be a marker of widespread inappropriate platelet activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194867     DOI: 10.1080/00207230500120401

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  9 in total

1.  Glycemia, triglycerides and disease severity are best associated with higher platelet activity in patients with stable coronary artery disease.

Authors:  Pavel P Osmancik; Frantisek Bednar; Heidi Móciková
Journal:  J Thromb Thrombolysis       Date:  2007-02-17       Impact factor: 2.300

2.  Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients.

Authors:  Ken Fukunaga; Yoshihiro Fukuda; Yoko Yokoyama; Kunio Ohnishi; Takeshi Kusaka; Tadashi Kosaka; Nobuyuki Hida; Yoshio Ohda; Hiroto Miwa; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

3.  A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction.

Authors:  Zhida Wang; Wang Cai; Shaolan Hu; Yufei Xia; Yao Wang; Qi Zhang; Liming Chen
Journal:  Arq Bras Cardiol       Date:  2017-07-10       Impact factor: 2.000

4.  Microparticles as novel biomarkers and therapeutic targets in coronary heart disease.

Authors:  Bo-Da Zhou; Ge Guo; Le-Min Zheng; Ling-Yun Zu; Wei Gao
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

Review 5.  Platelet-Derived Microvesicles in Cardiovascular Diseases.

Authors:  Maria T K Zaldivia; James D McFadyen; Bock Lim; Xiaowei Wang; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2017-11-21

Review 6.  Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation.

Authors:  Mirthe Dekker; Farahnaz Waissi; Nathalie Timmerman; Max J M Silvis; Leo Timmers; Dominique P V de Kleijn
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

7.  Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men.

Authors:  O Dotsenko; N Chaturvedi; S A McG Thom; A R Wright; J Mayet; A Shore; C Schalkwijk; A D Hughes
Journal:  J Thromb Haemost       Date:  2007-10       Impact factor: 5.824

8.  Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status.

Authors:  Xuguang Zhang; Susan C McGeoch; Alexandra M Johnstone; Grietje Holtrop; Alan A Sneddon; Sandra M MacRury; Ian L Megson; Donald W M Pearson; Prakash Abraham; Baukje De Roos; Gerald E Lobley; Niamh O'Kennedy
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

9.  Association between vascular access failure and microparticles in hemodialysis patients.

Authors:  Jung-Hwa Ryu; Su-Young Lim; Dong-Ryeol Ryu; Duk-Hee Kang; Kyu Bok Choi; Seung-Jung Kim
Journal:  Kidney Res Clin Pract       Date:  2012-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.